Please wait while we load the requested 10-Q report or click the link below:
https://last10k.com/sec-filings/report/1333493/000133349323000113/ehth-20230630.htm
November 2023
November 2023
August 2023
June 2023
May 2023
May 2023
February 2023
February 2023
January 2023
December 2022
CEO Comments | ||||||||
"eHealth delivered strong second quarter results with revenue and profitability ahead of our expectations driven in part by positive tail revenue, which reflects favorable commissions and persistency trends in our book of business and further validates our commissions receivable asset. We are well on track in our preparations for the Annual Enrollment Period and I am confident in eHealth’s ability to execute against our goal of returning to Medicare enrollment growth on a significantly improved operational and cost foundation in the fourth quarter. Further, the mid-point of our updated 2023 guidance now reflects adjusted EBITDA profitability, an important milestone for the organization." – Fran Soistman, Chief Executive Officer |
Results Overview |
Please wait while we load the requested 10-Q report or click the link below:
https://last10k.com/sec-filings/report/1333493/000133349323000113/ehth-20230630.htm
Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Ehealth, Inc..
Ehealth, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2023 10-K Annual Report includes:
Rating
Learn More![]()
Some of our marketing partners have tiered arrangements where the amount we pay the marketing partner per submitted application increases as the volume of submitted applications we receive from the marketing partner increases.
The constraints are applied to help ensure that commissions estimated to be collected over the estimated life of an approved member's plan are recognized as revenue only to the extent that it is probable that a significant reversal in the amount of cumulative revenue recognized will not occur when the uncertainty associated with future commissions receivable from the plan is subsequently resolved.
The increase in Medicare Advantage was primarily driven by favorable retention, partially offset by unfavorable commission rates due to carrier mix.
This was driven by a $50.9 million decrease in operating expenses, excluding stock-based compensation expense, depreciation and amortization, impairment, restructuring and other charges, and other expense, net, offset by a $18.9 million decrease in revenue.
Our effective tax rate for the three months ended June 30, 2023 was lower than the statutory federal tax rate due primarily to stock-based compensation adjustments and non-deductible lobbying expenses, partially offset by research and development credits and state taxes.
Our effective tax rate for...Read more
Our plan recommendation tool curates...Read more
Recent Accounting Pronouncements See Note...Read more
To a lesser extent, the...Read more
Variable marketing costs exclude fixed...Read more
The increase in net adjustment...Read more
The increase in net adjustment...Read more
The increase in constrained LTV...Read more
The Medicare segment consists primarily...Read more
Small business constrained LTV of...Read more
Increases in submitted applications resulting...Read more
Since our marketing and advertising...Read more
Member Acquisition Marketing initiatives are...Read more
As a result of positive...Read more
Adjustments for non-cash items primarily...Read more
Adjustments for non-cash items primarily...Read more
Six Months Ended June 30,...Read more
For ancillary health insurance plans,...Read more
Six Months Ended June 30,...Read more
Constrained LTV of commissions per...Read more
The following table shows estimated...Read more
The decrease in Medicare segment...Read more
A portion of our technology...Read more
The base rate is the...Read more
Six Months Ended June 30,...Read more
Six Months Ended June 30,...Read more
Variable marketing costs represent direct...Read more
Six Months Ended June 30,...Read more
Estimated Constrained Lifetime Value of...Read more
During the first six months...Read more
In periods of membership growth,...Read more
Six Months Ended June 30,...Read more
The increase was primarily driven...Read more
The increase was primarily driven...Read more
Other revenue decreased $1.7 million,...Read more
Variable marketing cost per IFP-equivalent...Read more
Ancillary product approved members declined...Read more
Our technology and content expenses...Read more
The increase in constrained LTV...Read more
The increase in Medicare Part...Read more
36 Six Months Ended June...Read more
The increase in Medicare segment...Read more
The increase in commission revenue...Read more
This was driven by a...Read more
This decline was driven by...Read more
This decline was driven by...Read more
43 Availability and Use of...Read more
The Minimum Asset Coverage Ratio...Read more
We have created a consumer-centric...Read more
35 Our cost of revenue...Read more
We are also in the...Read more
The constrained LTV of commissions...Read more
Our Individual, Family and Small...Read more
Our Individual, Family and Small...Read more
Overview We are a leading...Read more
During the Medicare annual enrollment...Read more
Our principal uses of cash...Read more
Ancillary product approved members declined...Read more
Financing Activities Six Months Ended...Read more
Our other income (expense), net,...Read more
During 2023, we are focusing...Read more
This was partially offset by...Read more
CC&E cost per IFP-equivalent approved...Read more
CC&E cost per MA-equivalent approved...Read more
The timing of open enrollment...Read more
Over the last several months,...Read more
The change was primarily due...Read more
The change was primarily due...Read more
The decrease in operating expenses...Read more
The decrease in operating expenses...Read more
Our future capital requirements will...Read more
Segment Profit (Loss) Three Months...Read more
Customer Care and Enrollment Customer...Read more
The numerator used to calculate...Read more
Our platform leverages technology to...Read more
This decrease was offset by...Read more
If we experience a significant...Read more
40 Our operating segment revenue...Read more
Other revenue increased $4.0 million,...Read more
Our omnichannel consumer engagement platform...Read more
Financial Statements, Disclosures and Schedules
Inside this 10-Q Quarterly Report
Material Contracts, Statements, Certifications & more
Ehealth, Inc. provided additional information to their SEC Filing as exhibits
Ticker: EHTH
CIK: 1333493
Form Type: 10-Q Quarterly Report
Accession Number: 0001333493-23-000113
Submitted to the SEC: Tue Aug 08 2023 4:22:54 PM EST
Accepted by the SEC: Tue Aug 08 2023
Period: Friday, June 30, 2023
Industry: Insurance Agents Brokers And Service